Who
Jesse Wayne Hall
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Aclaris Therapeutics.
In numbers
- Trades disclosed
- 12
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 May 2025
- Last trade
- 1 May 2026
- Last filed
- 5 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 May 2026filed 5 May 2026 | ACRS Aclaris TherapeuticsBiotechnology | SEC FORM 4 Code M | —36,375 | filing |
| 1 May 2026filed 5 May 2026 | ACRS Aclaris TherapeuticsBiotechnology | SEC FORM 4 Code F | $41K9,330 at $4.41 | filing |
| 1 May 2026filed 5 May 2026 | ACRS Aclaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —36,375 at $0.00 | filing |
| 1 May 2026filed 5 May 2026 | ACRS Aclaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —36,375 at $0.00 | filing |
| 1 May 2026filed 5 May 2026 | ACRS Aclaris TherapeuticsBiotechnology | SEC FORM 4 Code M | —36,375 | filing |
| 1 May 2026filed 5 May 2026 | ACRS Aclaris TherapeuticsBiotechnology | SEC FORM 4 Code F | $41K9,330 at $4.41 | filing |
| 2 Feb 2026filed 6 Feb 2026 | ACRS Aclaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —98,100 at $0.00 | filing |
| 2 Feb 2026filed 6 Feb 2026 | ACRS Aclaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —343,300 at $0.00 | filing |
| 2 Feb 2026filed 6 Feb 2026 | ACRS Aclaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —98,100 at $0.00 | filing |
| 2 Feb 2026filed 6 Feb 2026 | ACRS Aclaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —343,300 at $0.00 | filing |
| 1 May 2025filed 5 May 2025 | ACRS Aclaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —145,500 at $0.00 | filing |
| 1 May 2025filed 5 May 2025 | ACRS Aclaris Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —510,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.